BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10605313)

  • 1. [Anatomo-pathologic examination of breast cancer: a prerequisite for optimal therapeutic choice].
    Fridman V; Boniver J
    Rev Med Liege; 1999 Oct; 54(10):796-800. PubMed ID: 10605313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological parameters useful in predicting prognosis for patients with breast cancer.
    Hutter RV
    Monogr Pathol; 1984; (25):175-85. PubMed ID: 6377048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathologist in breast cancer: contemporary issues in the interdisciplinary approach.
    Ibarra JA
    Surg Oncol Clin N Am; 2000 Apr; 9(2):295-317. PubMed ID: 10757846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of axillary disease.
    Caudle AS; Cupp JA; Kuerer HM
    Surg Oncol Clin N Am; 2014 Jul; 23(3):473-86. PubMed ID: 24882346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
    Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM
    Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast carcinoma and breast saving therapy--a critical comment from the viewpoint of the pathologist].
    Prechtel K; Prechtel D
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):184-9. PubMed ID: 8682283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic-predictive factors and therapeutic choices in invasive carcinoma of the breast].
    Puglisi F; Di Loreto C; Beltrami CA
    Ann Ital Chir; 1999; 70(3):335-41. PubMed ID: 10466235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of breast cancer: what a pathologist needs to know.
    Allison KH
    Am J Clin Pathol; 2012 Dec; 138(6):770-80. PubMed ID: 23161709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer: axillary dissection--or an unnecessary procedure?].
    Schäfer P
    Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathologic-anatomic parameters for the prognosis of invasive breast cancer following amputation or saving the breast].
    Torhorst J
    Helv Chir Acta; 1989 Apr; 55(6):823-9. PubMed ID: 2666353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
    Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
    Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
    Petrik DW; McCready DR; Sawka CA; Goel V
    J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
    Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
    Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method].
    Houvenaeghel G; Martino M; Jacquemier J; Moutardier V; Tallet A; Viens P; Puig B; Bardou VJ
    Bull Cancer; 2003 May; 90(5):467-73. PubMed ID: 12850770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of pathologic prognostic factors in breast core needle biopsies.
    Sharifi S; Peterson MK; Baum JK; Raza S; Schnitt SJ
    Mod Pathol; 1999 Oct; 12(10):941-5. PubMed ID: 10530557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic approach for breast cancer classification].
    Penault-Llorca F; Mishellany F; Fouilhoux G; Trechot I; Maury F; Robin N; Cayre A; Dauplat MM
    Rev Prat; 2013 Dec; 63(10):1384-90. PubMed ID: 24579333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.